572 related articles for article (PubMed ID: 35293189)
1. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
[TBL] [Abstract][Full Text] [Related]
2. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
Romanò L; Velati C; Cambiè G; Fomiatti L; Galli C; Zanetti AR;
Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Chronic Infection in Blood Donors from Asian and African High or Medium Prevalence Areas: Comparison According to Sex.
Allain JP; Owusu-Ofori S; Ye X; Bisseye C; Chaar ME; Li C
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458403
[TBL] [Abstract][Full Text] [Related]
6. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.
Fopa D; Candotti D; Tagny CT; Doux C; Mbanya D; Murphy EL; Kenawy HI; El Chenawi F; Laperche S
Blood Transfus; 2019 Nov; 17(6):403-408. PubMed ID: 31846605
[TBL] [Abstract][Full Text] [Related]
7. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia.
Bubonja-Šonje M; Peruč D; Abram M; Mohar-Vitezić B
Ann Hepatol; 2024; 29(1):101156. PubMed ID: 37758118
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
12. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria.
Nna E; Mbamalu C; Ekejindu I
Pathog Glob Health; 2014 Jul; 108(5):223-8. PubMed ID: 24995918
[TBL] [Abstract][Full Text] [Related]
16. Anti-HBc-nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults.
Deng X; Guo X; Gu H; Wang D; Laperche S; Allain JP; Zang L; Candotti D
J Viral Hepat; 2022 Nov; 29(11):958-967. PubMed ID: 35876456
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection among Egyptian blood donors.
Said ZN; Sayed MH; Salama II; Aboel-Magd EK; Mahmoud MH; Setouhy ME; Mouftah F; Azzab MB; Goubran H; Bassili A; Esmat GE
World J Hepatol; 2013 Feb; 5(2):64-73. PubMed ID: 23646231
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
19. Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy.
Damiani AS; Holzmayer V; Galli C; De Nuzzo M; Anderson M; Cloherty G; Di Renzo N
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257771
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection: detection and significance.
Gerlich WH; Bremer C; Saniewski M; Schüttler CG; Wend UC; Willems WR; Glebe D
Dig Dis; 2010; 28(1):116-25. PubMed ID: 20460899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
